You are here:
Two key factors set the Vaccine Alliance apart from other actors in the field of international health aid:
In this section, we explain Gavi’s unique business model and the six ways it delivers "added value".
Donor and developing countries need to see proof of the value of new vaccines before investing.
Immunisation is a commitment for life that requires guaranteed, long-term funding.
Developing countries decide for themselves how best to use Gavi support for immunisation.
It's not enough to buy new vaccines. They have to safely reach every child.
Manufacturers will only make vaccines for poor countries if they know they can sell them .
National immunisation programes must survive long after Gavi support stops.
The Accelerated Vaccine Introduction Initiative is a showcase of the Gavi business model at work.
Gavi support had contributed to immunising 11 million children against pneumococcal disease by the end of 2013.
02 October 2013
Laos becomes first South East Asian nation to introduce pneumococcal vaccine
04 May 2013
Sojo Stories: Immunizing 250 Million Children By 2015
27 March 2013
Seth Berkley on Immunization in Pakistan
Heartfile eForum Blog
05 October 2012
GAVI Alliance CEO: Leadership Is About Vision and Responsibility, Not Power
28 September 2012
Vaccines and Ensuring the Health of Children No Matter Where They Live
The Huffington Post
06 August 2012
GAVI looks forward to strengthening cooperation with China: CEO
06 July 2012
Dagfinn Høybråten: GAVI’s mission to help fulfill MDGs
14 June 2012
How vaccination can stop 1.7m children dying this year
13 June 2012
One Year On: Delivering on the Promises of Vaccines for All
Huffington Post UK
08 June 2012
Putting an end to 7.6 million preventable child deaths - Dagfinn Høybråten
© Gavi 2014
modal window here